KUALA LUMPUR: The Attorney-General's Chambers (AGC) had to propose amendments to Malaysia's vaccine procurement agreement with Pfizer (Malaysia) Sdn Bhd, after finding clauses which favoured the supplier.
This was revealed in the White Paper on Covid-19 Vaccine Procurement Management released in Parliament on Thursday (June 8).
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
